Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cell Reports|September 30, 2016
Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell ActivitySabina Sangaletti, Claudio Tripodo, Alessandra Santangelo, et al.
Molecular Cancer Therapeutics|December 17, 2016
Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-βElena Jachetti, Alice Rigoni, Lucia Bongiovanni, et al.
Frontiers in Immunology|July 9, 2019
SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive ActivitiesSabina Sangaletti, Giovanna Talarico, Claudia Chiodoni, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 16, 2026
ZEB1 integrates stemness, differentiation blockade and immune suppression to orchestrate osteosarcoma aggressivenessAnna Zaccaria, Caterina Cascini, Chiara Ratti, et al.
Cancer Research|March 18, 2020
Infiltrating Mast Cell-Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal PhenotypeMaria Teresa Majorini, Valeria Cancila, Alice Rigoni, et al.
Frontiers in Immunology|June 4, 2021
CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress ConditionsBarbara Bassani, Claudio Tripodo, Paola Portararo, et al.
Elife|April 26, 2022
Neutrophil extracellular traps arm DC vaccination against NPM-mutant myeloproliferationClaudio Tripodo, Barbara Bassani, Elena Jachetti, et al.
Cancer Research|May 25, 2017
Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal RemodelingClaudio Tripodo, Alessia Burocchi, Pier Paolo Piccaluga, et al.
Pageof 3